Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pacific Biosciences of California Inc PACB

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing... see more

Recent & Breaking News (NDAQ:PACB)

Levi & Korsinsky Reminds Shareholders of an Investigation into Pacific Biosciences of California, Inc. (PACB) Regarding Potential Securities Fraud Allegations

Accesswire August 6, 2024

Singapore's National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia

GlobeNewswire August 5, 2024

Pacific Biosciences of California, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - PACB

Accesswire August 5, 2024

PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm

Business Wire August 2, 2024

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Pacific Biosciences of California, Inc. (PACB)

Accesswire August 1, 2024

Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing

GlobeNewswire July 23, 2024

PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024

GlobeNewswire July 15, 2024

PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database

PR Newswire June 10, 2024

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases

PR Newswire May 15, 2024

PacBio Announces First Quarter 2024 Financial Results

PR Newswire May 9, 2024

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance

PR Newswire April 16, 2024

Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes

PR Newswire March 27, 2024

PacBio Grants Equity Incentive Award to New Employee

PR Newswire March 22, 2024

PacBio Announces PureTarget(TM) Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions

PR Newswire March 12, 2024

PacBio to Present at Upcoming Investor Conferences

PR Newswire February 26, 2024

PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

PR Newswire February 15, 2024

Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch

PR Newswire February 13, 2024

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

PR Newswire February 5, 2024

PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024

PR Newswire January 25, 2024

PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions

PR Newswire January 15, 2024